Skip to content

Partnership Optimizes Weight Management in Primary Care

Primary Care Obesity Management in the Southeast_PROMISE

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02959021
Acronym
PROMISE
Enrollment
375
Registered
2016-11-08
Start date
2017-01-31
Completion date
2025-12-01
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

weight loss, behavioral, primary care, lifestyle

Brief summary

The purpose of this study is to examine whether a primary care weight management intervention delivered by peer coaches produces greater weight loss than a self-directed program without peer coach support.

Interventions

BEHAVIORALweight loss intervention - self directed
BEHAVIORALweight loss intervention - peer coach

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 21-75 years * Body mass index (BMI) 30-50 kg/m2 * Receiving primary care services at one of the practices participating in this study

Exclusion criteria

* Uncontrolled hypertension (blood pressure \>160/100 mm Hg at screening) * Any of the following other medical conditions: myocardial infarction or cerebrovascular accident within the last six months; unstable angina within the past six months; NYHA Class III or IV congestive heart failure; type 1 diabetes; cancer requiring treatment in past five years (exception: non-melanoma skin cancer); and chronic lung diseases that limit physical activity * Current use of any of the following medications: antipsychotic agents, monoamine oxidase inhibitors, systemic corticosteroids, or chemotherapeutic drugs; prescription weight loss medications (past six months) * Unwilling or unable to do any of the following: give informed consent; read/understand English; accept random assignment; travel to the intervention site * Likely to relocate out of the area in the next 2 years * Participation in another randomized research project * Weight loss \> 10 pounds in past six months * History of bariatric surgery

Design outcomes

Primary

MeasureTime frameDescription
body weight6, 12, and 18 monthschange in body weight (kg) from baseline to follow-up assessments

Secondary

MeasureTime frameDescription
treatment adherence6, 12, and 18 monthsTreatment adherence will be assessed by the number of treatment sessions and phone calls completed.
treatment burden6, 12, and 18 monthsBehavioral burden of treatment will be assessed with self-report questionnaires including items about the perceived burden of behavioral targets such as self-monitoring, dietary changes, maintaining physical activity, and the impact of treatment on social relationships.
treatment satisfaction6, 12, and 18 monthsParticipants will complete self-report items assessing their attitudes and satisfaction regarding the weight loss intervention and weight loss achieved.
side effects6, 12, and 18 monthsSymptom checklist including minor (e.g., constipation, dry mouth) and more severe events (e.g., cardiovascular events) will be administered to assess potential adverse side effects associated with treatment.
physical activity6, 12, and 18 monthsSelf-reported physical activity assessed via the Paffenbarger Physical Activity Questionnaire (PPAQ).
physical and social functioning6, 12, and 18 monthsItems from the Patient Reported Outcome Measurement Information System (PROMIS) will be administered, including the 8-item short forms for physical and social functioning.
mood6, 12, and 18 monthsThe Patient Health Questionnaire-8 (PHQ-8), a validated self-report measure of depressive symptoms experienced over the past two weeks, will be administered.
healthcare utilization6, 12, and 18 monthsSelf-reported utilization of health care services (hospitalizations, ER/physician office visits, prescription drugs, etc.) and out-of-pocket costs will be collected.
quality of life6, 12, and 18 monthsQuality of life will be assessed through the validated Short-Form 12 (SF-12), which provides measures of health-related quality of life for physical and mental health.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026